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Background: We produced a novel model of bladder outlet obstruction (BOO) by periurethral injection of
hyaluronic acid and compared the cystometric features, postoperative complications, and histopathological changes
of that model with that of traditional open surgery.
Methods: Forty female Sprague-Dawley rats were divided into three groups. Fifteen rats were subcutaneously injected
with 0.2 ml hyaluronic acid at 5, 7, and 12 o’clock around the urethral orifice. Another fifteen rats underwent traditional
open partial proximal urethral obstruction surgery, and 10 normal rats used as controls. After 4 weeks, filling cystometry,
postoperative complications, and histopathological features were evaluated in each group. Three rats were also observed
for 12 weeks after hyaluronic acid injection to evaluate the long-term effect.
Results: Hyaluronic acid periurethral injection caused increased maximum cystometric capacity, maximum bladder
pressure, micturition interval, and post-void residual urine volume compared with control (p < 0.01). The injection group
had significantly shorter operative time, less incidence of incision infection and bladder stone formation compared with
the surgery group (p < 0.01). Hematoxylin and eosin (HE) staining showed suburothelial and interstitial hyperemia edema
and smooth muscle hypertrophy in both injection and surgery bladders; these were not observed in the control group.
Bladder weight and thickness of smooth muscle in the injection and surgery groups were significantly greater than
those in the control group (p < 0.01). Urethral epithelial hyperplasia and lamina propria inflammation were observed in
the surgery group but not in the injection or control groups. Rats periurethrally injected hyaluronic acid were stable the
compound was not fully absorbed in any rat after 12 weeks.
Conclusions: Hyaluronic acid periurethral injection generates a simple, effective, and persistent animal model of BOO
with lower complications, compared with traditional surgery.
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Bladder outlet obstruction (BOO) is a common uro-
logical chronic condition in which the urine flow from
the urinary bladder through the urethra is impeded.
BOO can result from several diseases, including benign
prostatic hyperplasia and urethral stricture in adults
[1,2]. To better understand the effect of this condition
on bladder structure and function, several experimental
animal models have been established [3]. Those animal
models that recreate BOO are critical to understanding
the pathophysiology of many diseases related bladder* Correspondence: lugeng8@hotmail.com
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unless otherwise stated.function, and to evaluating the effects of various
pharmacologic therapies.
The most widely used methodological approaches to
creating BOO are the partial urethral obstruction (PUO)
animal models. In these animal models, a ligature, cuff,
or ring is surgically placed around the outlet of the cath-
eterized bladder, so that when the catheter is removed,
the bladder experiences increased urethral resistance
[4-7]. Although animal models cannot perfectly recap-
itulate symptoms observed in clinic, evidence indicates
that PUO rats have similar storage and micturition
symptoms as human BOO patients [8-10].
However, massive trauma caused by open surgery
causes some complications such as incision infection
and bladder stone formation. It is also difficult toThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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material from rings in surgery PUO models. Therefore, es-
tablishing a relevant, reproducible, and minimally invasive
BOO animal model would be useful.
Bulking agents have previously been injected to treat
urinary incontinence in clinic. The injection seeks to in-
crease bladder outlet resistance by oppressing the urethra
and thereby reducing urinary leakage in patients with
stress urinary incontinence [11]. The establishment of a
BOO animal model is possible by a similar principle.
Hyaluronic acid is a viscous mucopolysaccharide found
in the connective tissue space. It is ideal for BOO model
establishment because it is stable and histocompatible.
We aimed to establish a novel BOO animal model by
hyaluronic acid periurethral injection, and to compare
the effects and related complications of this technique
with traditional PUO surgery.
Methods
Animal model preparation
All experimental protocols were approved by the Animal
Research Ethics Committee of the Third Military Medical
University. Forty female Sprague-Dawley rats were studied
(weighing 220–260 g, Animal Center of the Third Military
Medical University). All animals were anesthetized with
sodium pentobarbital (50 mg/kg, i.p.) before procedures.
The periurethral injection group (n = 15) underwent
PUO by subcutaneous injection of 0.2 ml hyaluronic
acid (Restylane, Q-Med, Uppsala,Sweden) at 5, 7, and
12 o’clock around the urethral orifice (Figure 1A). Animals
in the surgery group (n = 15) underwent open surgery as
previously described [12]. Briefly, a midline abdominal inci-
sion was made and the bladder and proximal urethra were
dissected from the surrounding tissue. To create intra-
vesical obstruction, a polyethylene tube (1.0 mm outer
diameter) was placed beside the proximal urethra and
a three-zero silk ligature was tied around the urethraFigure 1 Partial urethral obstruction (PUO) animal model. (A) Hyaluronand catheter. Then, the catheter was removed and the
abdominal incision was closed (Figure 1B). Another
ten normal rats were used as the control group. Four
weeks later, mortality rates, complications, filling
cystometry, and histopathological studies were evalu-
ated in each group. To evaluate the long-term effect of
hyaluronic acid in rats, another three rats were periur-
ethrally injected with hyaluronic acid. The rats were
observed for 12 weeks, at which point urethral anat-
omy was observed to evaluate whether or not hyalur-
onic acid was still present.Cystometric study
Four weeks after surgery or injection, cystometric stud-
ies were performed on all animals as previously de-
scribed. Animals were anesthetized as described above,
and the bladders were catheterized via an incision at the
bladder dome with a 0.6 mm inner diameter catheter.
External bladder filling was carried out using an infusion
pump (3 M, Saint Paul, MN, USA) at a constant rate of
12 ml/h until micturition was detected. A cystometry
catheter was connected to an external pressure trans-
ducer (RM-6240B, Chengdu, China) for the measure-
ment of the intravesical pressure. Animals underwent
cystometries by irrigation of bladders with normal saline
at room temperature and the curves of intravesical pres-
sure and frequency of micturition were recorded. In
each animal, approximately 10–12 voiding cycles were
recorded and then the mean of the voiding cycles was
calculated. The following parameters were evaluated:
maximum cystometric capacity (MCC), maximal mictur-
ition pressure (Pmax), frequency (micturition interval),
post-voiding residual volume (PRV), and detrusor insta-
ble contraction (DI). DI was defined as the significant
non-voiding detrusor contractions (NVCs) higher than
10 cmH2O.ic acid periurethral injection (B) Proximal urethral ligation surgery.
Table 1 Post-operative complications in injection,
surgery, and control groups
Groups Mortality Incision infection Bladder stone
Injection group N = 15 0 0 0
Surgery group N = 15 1 2 2
Control group N = 10 0 0 0
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Four weeks after operation or injection, the animals
were sacrificed and the bladders in each group were ex-
cised en bloc with the urethra. Bladders were weighed,
and the ratio of bladder weight (mg) to body weight (g)
was calculated in each surviving animal. Specimens of
kidney, ureter, bladder, and urethra from each of the
groups were immediately fixed with 10% formalin. After
fixation, the tissues were embedded in paraffin, and 5-μm-
thick tissue sections were cut. All of the specimens were
stained using hematoxylin and eosin (HE) and viewed
under a light microscope to evaluate histopathological
changes. The thickness of the smooth muscle layer be-
tween the serosa and submucosa of the bladder dome
were measured and compared among the three groups.
All histopathological findings were determined by a path-
ologist in a blinded fashion.
Statistical analysis
Analysis was performed by SPSS11.0. All data were analyzed
for normality of distribution utilizing the Kolmogorov-
Smimov test and presented as the mean ± SEM. Data were
subjected to t-test. For all statistical tests, P < 0.05 was con-
sidered significant.
Results
All animals in the injection and control groups survived
until the day of evaluation. One of the animals in the
surgery group died because of severe incision infection
and bladder stones. The average operative time of injec-
tion was 3.5 ± 0.3 minutes, which was significantly
shorter than that in the surgery group with 15.6 ± 5.4 mi-
nutes (p < 0.01).
Two animals had incision infections and bladder stone
formation (Figure 2) in the surgery group. There were
no complications in the injection or control groups
(Table 1). All animals with complications were excluded
from the cystometric study.
Filling cystometric data showed that both the injection
and surgery procedures caused increased MCC, Pmax,Figure 2 Bladder stone formation in surgery animal after
4 weeks of ligation.frequency, and PRV compared with the control (p <
0.01) (Table 2). Both methods of obstruction caused
cystometric changes in the bladder consistent with de-
trusor overactivity, which showed increasing spontan-
eous activity displayed as non-voiding contractions
(NVCs) greater than 10 cmH2O during the bladder stor-
age period (Figure 3).
After the animals were sacrificed, gross and microscopic
anatomical changes of the organs were examined. There
was no significant difference in body weight among the
control (209.2 ± 16.2 g), surgery (210.2 ± 14.6 g), and in-
jection (206.1 ± 17.3 g) rats at 4 weeks. However, the
bladder weights in the surgery (3.1 ± 0.6 g) and injection
(2.6 ± 0.3 g) groups were significantly greater than those
in the control group (0.9 ± 0.1 g). The ratio of bladder
weight (mg) to body weight (g) was used to evaluate
bladder hypertrophy. The ratio increased in both the
surgery (14.1 ± 3.7) and injection groups (12.6 ± 1.3)
compared with the control group (4.7 ± 0.3, p < 0.01).
There was a significant increase in the thickness of smooth
muscle in the bladders of the injection (805 ± 77 μm) and
surgery groups (961 ± 186 μm) compared with the control
group (442 ± 39 μm, p < 0.01).
HE staining showed that all rats in three groups had
normal kidneys and ureters. Examination of the bladder
wall revealed an enlarged and hypertrophied bladder in
each rat in the surgery and injection groups. Suburothe-
lium inflammatory changes were observed in all surgery
rats but not in those rats in the injection group (Figure 4A
and B). In the proximal urethra, signs of epithelial prolifer-
ation and inflammation were observed around the urethra
ligation in all surgery rats (Figure 5B). In some rats (3 of
the 12 rats), severe epithelial proliferation caused squa-
mous metaplasia near the ligation in the surgery group
(Figure 5E). Unlike the surgery ligation rats, the urethra in
the injection rats showed mild smooth muscle hyper-
trophy without epithelial proliferation and suburothelium
inflammation (Figure 5A). Injected hyaluronic acid can be
seen as a red dyed zone with a clear boundary, which
oppressed the surrounding tissue without any inflamma-
tory signs (Figure 5D). Histological study of the rats in the
control group did not reveal any abnormalities (Figures 4C
and 5C).
After 12 weeks, three hyaluronic acid injected rats
were sacrificed and urethral anatomy was observed. The
semitransparent hyaluronic acid gel was still present








Injection group N = 15 1.66 ± 0.17* 39.47 ± 3.13* 152.13 ± 20.13* 0.26 ± 0.10* 3.21 ± 0.42*
Surgery group
0.28 ± 0.13* N = 12
1.81 ± 0.59* 42.11 ± 7.99* 165.23 ± 56.30* 2.85 ± 0.67*
Control group N = 10 1.38 ± 0.13 31.28 ± 3.37 256.2 ± 25.55 0 0
Both injection and surgery groups caused typical obstruction characteristics with increasing MCC, Pmax, frequency, and PRV compared with the control group.
The data are shown as mean value ± SD.
*p < 0.05 compared to control group.
#the frequency of NVC was calculated in every 10 minutes.
MCC, maximum cystometric capacity; Pmax maximum bladder pressure during micturition; PRV, post-void residual urine volume.
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of the residual hyaluronic acid was the same between
the 4 and 12 week rats. Therefore, there was no signifi-
cant absorption of hyaluronic acid after 12 weeks.Discussion
The partial bladder neck ligation model is widely used in
many studies on BOO, but the procedure is complex
and there is a high risk of complications. Operative time
and the degree of ligation are difficult to standardize,
and severe inflammation around the urethral ligation
can often result in excessive obstruction. Further, the fi-
brous scar in the abdominal skin and muscle, which
does not occur in patients with BOO, may affect the ac-
curacy studies using this model [13]. Placing a metal ring
loosely around the proximal urethra has been used to
create BOO models [7,14]. However, rejection of the for-
eign material is difficult to avoid.Figure 3 Filling cystometric curves in injection, operation, and contro
significant decreases in micturition interval and frequent non-voiding contractio
frequency and good bladder compliance. *Non-voiding contractions (NVCs); ↓:Using bulking agents to increase bladder outlet resist-
ance has been used in urinary incontinence treatment
for some human patients. However, clinical case reports
indicate that periurethral polytetrafluoroethylene (Tef-
lon) injection can cause BOO in some patients [15].
Hyaluronic acid is an anionic, nonsulfated glycosamino-
glycan that is distributed widely throughout connective,
epithelial, and neural tissues. It is popular for filling soft
tissue defects such as facial wrinkles or lip augmentation
in plastic surgery because it is effective, easy to administer,
and safe. Some urologists have attempted to use hyalur-
onic acid injection to treat vesicoureteral reflux in children
[16-18]. Hyaluronic acid is biocompatible and can be exist
stably in the body, so it could be used to observe long-
term pathophysiological changes in some chronic diseases.
Clinical trials indicate that hyaluronic acid can persist up
to 6–18 after injection in humans [19]. Therefore, hyalur-
onic acid appears to be a perfect agent to creating and
simulating urinary obstruction. However, no reportedl rats. (A) and (B) show respective injection and surgery bladders with
ns (NVCs) in the storage phase. (C) Control bladder displayed micturition
Micturition.
Figure 4 Histological characteristics of injection, operation, and control bladders. There was a significant increase in the thickness of
smooth muscle in the bladders of the injection (A) and surgery groups (B) compared with the control group (C). Suburothelium and interstitial
hyperemia edema and smooth muscle hypertrophy were found in both injection and surgery bladders. Severe suburothelium inflammation and
hyperemia were observed in the surgery group but not in the injection group.
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of hyaluronic acid.
In this study, we used hyaluronic acid injection to pro-
duce BOO in rats. Using this method, no open surgery
or ligation was needed, greatly simplifying the oper-
ational process. Therefore, the procedure is safer and
more stable compared with traditional surgery. More-
over, the degree of obstruction was easier to control with
hyaluronic acid injection. Filling cystometry studies
showed that periurethral injection of hyaluronic acid
could achieve the same bladder outlet obstructive effects
as open surgery. The detrusor overactivity presenting ofFigure 5 Histological characteristics of injection, operation, and contr
mild smooth muscle hypertrophy without epithelial proliferation and subu
proliferation and inflammation were seen around the urethra ligation in th
(D). Squamous metaplasia because of severe epithelial proliferation and infNVCs appeared in both the injection and surgery blad-
ders. Furthermore, the observed complication rate in the
surgery group was higher than that in the injection
group. In histological observation, both injection and
surgery bladders showed suburothelial and interstitial
hyperemia edema and smooth muscle hypertrophy,
which are the compensatory responses after urinary tract
obstruction. However, significant differences in the blad-
der and urethra were observed between the surgery and
injection groups. In the rats with a urethral ligation, the
bladder and urethra showed signs of fibrosis, inflamma-
tion, and muscular hypertrophy. The rats with injectionol proximal urethras. The proximal urethra in injection rats showed
rothelium inflammation (A) similar to the control (C). Epithelial
e surgery group (B). Injected hyaluronic acid is indicated with an arrow
lammation is indicated with an asterisk in the surgery group (E).
Figure 6 Urethral anatomy after hyaluronic acid injection for 4 and 12 weeks. Injected gel hyaluronic acid stably existed around the
urethra. The size of the residual hyaluronic acid was not different from 4 weeks (A) to 12 weeks (B). Normal rat urethral anatomy was also
performed as control (C). Hyaluronic acid is indicated with an asterisk, and the urethra is indicated with an arrow.
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proliferation or lamina propria inflammation. Therefore,
the injection of hyaluronic acid seems to cause only
some physiological changes in muscular thickening of
the bladder wall and increased bladder weight, and mini-
mizes the interference of inflammation. These symptoms
more closely mimic those observed of BOO in clinic. To
further evaluate the long-term homeostasis of hyaluronic
acid, we observed urethral anatomy and found that
injected hyaluronic acid was still present after 12 weeks.
This suggests that the BOO model is effective for longer
examinations. The cystometry data in the injection group
had a smaller standard deviation than that in the surgical
group, which indicated that the model is more stable and
repeatable.While hyaluronic acid is expensive, the amount neces-
sary for injection in rats is small. Considering that it sig-
nificantly reduced the amount of animals and time
required for study, we believe that it is more cost-effective
than the traditional surgery model.Conclusions
We demonstrated that periurethral injection of hya-
luronic acid creates a relatively simple, effective, and
persistent animal model of BOO that has fewer com-
plications than that of the traditional surgery model.
The model is simple to establish and provides consist-
ent pathophysiological changes of BOO that will be
useful for future study.
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